Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients. Aug 2010 - Br. J. Haematol.; 150(5):1365-2141 [PMID:20618329] [Yi Q] [Szmania S] [Freeman J] [Qian J] [Rosen NA] [Viswamitra S] [Cottler-Fox M] [Barlogie B] [Tricot G] [van Rhee F]
Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond. Jan 2008 - Am. J. Hematol.; 83(2):0361-8609 [PMID:17722077] [Zhou Y] [Zhang L] [Romaguera J] [Delasalle K] [Han X] [Du X] [Kwak L] [Yi Q] [Wang M]
Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96. Dec 2005 - Clin. Cancer Res.; 11(24 Pt 1):1078-0432 [PMID:16361569] [Qian J] [Wang S] [Yang J] [Xie J] [Lin P] [Freeman ME] [Yi Q]
Dendritic cell-based immunotherapy in multiple myeloma. Feb 2004 - Leuk. Lymphoma; 44(12):1042-8194 [PMID:14959845] [Yi Q]
Optimizing dendritic cell-based immunotherapy in multiple myeloma. Apr 2002 - Br. J. Haematol.; 117(2):0007-1048 [PMID:11972511] [Yi Q] [Desikan R] [Barlogie B] [Munshi N]
